Á lódáil...
Somatostatin receptor radionuclide therapy in neuroendocrine tumors
Peptide receptor radionuclide therapy (PRRT) using (177)Lu-DOTATATE has been approved for the treatment of gastroenteropancreatic NETs. An understanding of benefits and risks is important for the appropriate implementation of this therapy. This review summarizes study data supporting the use of radi...
Na minha lista:
| Foilsithe in: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8118168/ https://ncbi.nlm.nih.gov/pubmed/33608483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-20-0360 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|